MediaMedic

Building a Health Defense Line, Focusing on China Anemia Day on August 18th: Caring for the Source of Life, Starting with Understanding Anemia

By Peng Longmei 2025.02.25

In the vast river of life, blood flows like an unceasing stream, nourishing every inch of land and supporting the vitality and vigor of every life. Anemia, a seemingly inconspicuous…

Cutting-edge Bi-monthly: July Literature Digest (Part 1)

By Mourabit Halima 2025.02.25

Introduction: In this era of information explosion, how can one quickly access the latest developments in the field? Here, we select the latest literature in the field every month, focusing…

Dr. Zefei Jiang: Highlights, Innovations, and Reflections | 2024 Breast Cancer Summer Forum · Northern Salon

By Mourabit Halima 2025.02.25

Editor's Note: On July 27-28, 2024, the "2024 Breast Cancer Summer Forum · Northern Salon" was grandly held at Beijing Shougang Park. The conference upheld the philosophy of "learning and…

ESMO 2024丨Key Research in Hematological Malignancies (Mini oral)

By Zhan Cheng 2025.02.25

The 2024 European Society for Medical Oncology (ESMO) Annual Congress will take place from September 13th to 17th in Barcelona, Spain. As an annual celebration in the field of oncology,…

Dr. Nicolaus Kroger: New Perspectives on Myelofibrosis Treatment – Focusing on Post-Transplant Management and Minimal Residual Disease Monitoring

By Mourabit Halima 2025.02.25

In the field of myelofibrosis treatment, allogeneic hematopoietic stem cell transplantation (allo-HSCT) serves as a curative approach, and the optimization of related strategies is particularly crucial. Recently, at the 12th…

Advancing Early-Stage Breast Cancer Monitoring with ctDNA Structural Variant Detection

By Peter W. PENG 2025.02.25

A recent study published in Clinical Cancer Research (Jan 9, 2025) highlights the potential of structural variant (SV)-based circulating tumor DNA (ctDNA) detection in early-stage breast cancer (EBC). Unlike traditional…

Phase 3 EMBER-3 Trial: Imlunestrant in Advanced Breast Cancer

By Mourabit Halima 2025.02.25

A study published in NEJM on December 11, 2024, led by Komal L. Jhaveri and colleagues, evaluated Imlunestrant, a next-generation oral selective estrogen receptor (ER) degrader, in ER-positive, HER2-negative advanced…

Three First-Line Strategies for EGFR-Mutant NSCLC: How to Choose the Right One?

By Mourabit Halima 2025.02.25

Clinicians and researchers continue to seek targeted treatment strategies for EGFR-mutant non-small cell lung cancer (NSCLC), with an increasing number of clinical trials evaluating combination therapies. Two recent high-profile studies, the FLAURA-2 and MARIPOSA trials, have led to the FDA approval of new first-line treatment options for EGFR-mutant NSCLC in 2024.

Honoring Dr. Abdullah Tarik Aslan and His Research on Antibiotic-Associated Nephrotoxicity

By Mourabit Halima 2025.02.25

Dr. Abdullah Tarik Aslan, alongside his colleagues, has led an important multinational, multicenter cohort study investigating the risk of acute kidney injury (AKI) in patients receiving piperacillin-tazobactam (TZP) with either vancomycin (VAN) or teicoplanin (TEI).

Unlocking the Potential of Antibody-Drug Conjugates in Pancreaticobiliary Cancers: Mechanisms and Key Selection Criteria

By Mourabit Halima 2025.02.24

Antibody-drug conjugates (ADCs) have emerged as a promising treatment modality for pancreaticobiliary cancers, offering targeted delivery of cytotoxic agents while minimizing systemic toxicity. Dr. Lei Zheng’s presentation at the ASCO…

The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders

The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing

The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology

The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation

The 14th Lu Daopei Hematology Forum | Dr. Shu Yan: Stratified Prevention and Control, Comprehensive Management—Strategies for the Diagnosis and Treatment of Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation

The 14th Lu Daopei Hematology Forum | Dr. Jiujiang He: Establishing Venetoclax as a Cornerstone and Exploring Standardized Practice—Clinical Applications and Future Perspectives of Venetoclax in AML

the 14th Lu Daopei Hematology Forum丨Dr. Xiaosu Zhou: Decoding the “Genetic Code” of Atypical APL — Far Greater Complexity and Heterogeneity Than Expected

Frontiers in Immunology | Germline Genetic Susceptibility Genes May Enable More Precise Donor Selection for Hematopoietic Stem Cell Transplantation — Clinical Insights from a 558-Patient Transplant Cohort

Nature Reviews | The International Chinese Young Scholars Alliance for the Study of the Liver Facilitates Global Collaboration

ESMO 2026丨Looking Ahead: A Quick Review of 26 Chinese Hematologic Oncology Studies Featured at ESMO

The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders

The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing

Building a Health Defense Line, Focusing on China Anemia Day on August 18th: Caring for the Source of Life, Starting with Understanding Anemia

Cutting-edge Bi-monthly: July Literature Digest (Part 1)

Dr. Zefei Jiang: Highlights, Innovations, and Reflections | 2024 Breast Cancer Summer Forum · Northern Salon

ESMO 2024丨Key Research in Hematological Malignancies (Mini oral)

Dr. Nicolaus Kroger: New Perspectives on Myelofibrosis Treatment – Focusing on Post-Transplant Management and Minimal Residual Disease Monitoring

Advancing Early-Stage Breast Cancer Monitoring with ctDNA Structural Variant Detection

Phase 3 EMBER-3 Trial: Imlunestrant in Advanced Breast Cancer

Three First-Line Strategies for EGFR-Mutant NSCLC: How to Choose the Right One?

Honoring Dr. Abdullah Tarik Aslan and His Research on Antibiotic-Associated Nephrotoxicity

Unlocking the Potential of Antibody-Drug Conjugates in Pancreaticobiliary Cancers: Mechanisms and Key Selection Criteria

The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders

The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing

The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology

The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.